Evidence map›Paper›PMID 42472136›Full record

ArticleCureus2026

Silent but Distinct: Rare Adenoid Cystic Carcinoma of the Breast.

Soumiya Samba, Soufiane Berhili, Ahmed BenSghier, Mohamed Moukhlissi, Loubna Mezouar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Soumiya SambaDepartment of Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Soufiane BerhiliDepartment of Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Ahmed BenSghierDepartment of Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Mohamed MoukhlissiDepartment of Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Loubna MezouarDepartment of Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenoid cystic carcinoma (ACC) of the breast is an exceptionally rare malignancy, representing less than 0.1% of all breast cancers. Although it often demonstrates a triple-negative immunophenotype, its clinical course is typically more indolent than conventional triple-negative breast carcinomas. We report the case of a 64-year-old woman who presented with spontaneous nipple discharge from the left breast. Imaging revealed a suspicious lesion (Breast Imaging-Reporting and Data System (BI-RADS 5), leading to a core needle biopsy and tumorectomy, which identified a 2 cm invasive carcinoma of no special type. Completion mastectomy with axillary lymph node dissection revealed an 18 mm residual grade 1 tumor with clear margins and no nodal involvement. Immunohistochemistry confirmed a triple-negative profile, and staging CT scans showed no evidence of distant metastasis. The patient subsequently underwent adjuvant radiotherapy to the left chest wall. Given these findings, including complete surgical resection, absence of nodal involvement, and lack of distant metastasis, the clinical course is consistent with the favorable prognosis typically observed in breast ACC. This case highlights the diagnostic challenges, distinctive pathological features, and favorable outcomes associated with this rare entity, emphasizing the importance of accurate histopathologic evaluation and appropriate surgical management in guiding long-term prognosis.

Indexed as

adenoidbreastcarcinomacystic carcinomaradiation

Identifiers

PMID42472136
PMCPMC13379761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.